Dianthus Therapeutics, Inc. (DNTH)
85.51
-2.53
(-2.87%)
USD |
NASDAQ |
Oct 06, 16:00
85.51
0.00 (0.00%)
After-Hours: 17:58
Dianthus Therapeutics Price to Book Value : 3.998 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 05, 2026 | 4.116 |
| October 02, 2026 | 4.124 |
| October 01, 2026 | 4.129 |
| September 30, 2026 | 4.117 |
| September 29, 2026 | 4.075 |
| September 28, 2026 | 4.106 |
| September 25, 2026 | 4.140 |
| September 24, 2026 | 4.241 |
| September 23, 2026 | 4.369 |
| September 22, 2026 | 4.598 |
| September 21, 2026 | 4.510 |
| September 18, 2026 | 4.526 |
| September 17, 2026 | 4.728 |
| September 16, 2026 | 4.792 |
| September 15, 2026 | 4.898 |
| September 14, 2026 | 5.035 |
| September 11, 2026 | 4.965 |
| September 10, 2026 | 4.829 |
| September 09, 2026 | 5.005 |
| September 08, 2026 | 5.102 |
| September 04, 2026 | 5.054 |
| September 03, 2026 | 5.043 |
| September 02, 2026 | 4.967 |
| September 01, 2026 | 4.985 |
| August 31, 2026 | 4.938 |
| Date | Value |
|---|---|
| August 28, 2026 | 4.949 |
| August 27, 2026 | 5.215 |
| August 26, 2026 | 5.179 |
| August 25, 2026 | 5.242 |
| August 24, 2026 | 5.146 |
| August 21, 2026 | 5.194 |
| August 20, 2026 | 5.120 |
| August 19, 2026 | 5.316 |
| August 18, 2026 | 5.402 |
| August 17, 2026 | 5.370 |
| August 14, 2026 | 5.422 |
| August 13, 2026 | 5.124 |
| August 12, 2026 | 5.256 |
| August 11, 2026 | 5.072 |
| August 10, 2026 | 5.227 |
| August 07, 2026 | 5.093 |
| August 06, 2026 | 5.139 |
| August 05, 2026 | 5.26 |
| August 04, 2026 | 5.162 |
| August 03, 2026 | 4.957 |
| July 31, 2026 | 4.999 |
| July 30, 2026 | 5.266 |
| July 29, 2026 | 4.867 |
| July 28, 2026 | 4.751 |
| July 27, 2026 | 4.886 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Verastem, Inc. | 14.05 |
| ACADIA Pharmaceuticals, Inc. | 2.601 |
| Alnylam Pharmaceuticals, Inc. | 22.13 |
| Savara, Inc. | 6.641 |
| Vericel Corp. | 5.538 |
Price to Book Value Related Metrics
| PS Ratio | 2097.64 |
| PEG Ratio | -0.7470 |
| Price | 85.51 |
| Earnings Yield | -4.86% |
| Market Cap | 4.686B |
| PEGY Ratio | -0.7470 |